A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse

Clinical trial NCT01111903 · COMPLETED

Trial details

NCT number: NCT01111903
Sponsor: ARCAGY/ GINECO GROUP
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Recurrent

Start date: 2009-05-01
Primary completion: 2014-12-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.